Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 09 2021 - 5:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2021
Commission File Number: 001- 39167
Molecular Data Inc.
11/F, Building 15, 2177 Shenkun Road
Minhang District, Shanghai 201106
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
EXHIBIT INDEX
Exhibit No.
|
|
Description
|
99.1*
|
|
Molecular Data has raised up to USD 7.5 million from an accredited investor
|
* Exhibit 99.1 is furnished herewith solely for the purpose of meeting the requirements under Nasdaq Stock Market Rule 5250(c)(2) in connection with submission of an interim balance sheet and income statement as of the end of its second quarter.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Molecular Data Inc.
|
|
|
|
By
|
:
|
/s/ Steven Foo
|
|
Name
|
:
|
Steven Foo
|
|
Title
|
:
|
Chief Financial Officer
|
Date: April 9, 2021
3
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Apr 2024 to May 2024
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Molecular Data Inc (NASDAQ): 0 recent articles
More Molecular Data Inc. News Articles